Inflammatory Myopathies and Dermatomyositis

OBJECTIVE: The 1980 American College of Rheumatology (ACR) classification criteria for systemic sclerosis (SSc) lack sensitivity for early SSc and limited cutaneous SSc. The present work, by a joint committee of the ACR and the European League Against Rheumatism (EULAR), was undertaken for the purpose of developing ne…

• MURAT İNANÇ

Özet henüz yok.

• MURAT İNANÇ

Özet henüz yok.

• ÖMER KARADAĞ

Özet henüz yok.

Özet henüz yok.

• MURAT İNANÇ

Özet henüz yok.

• BERİL TALİM

Özet henüz yok.

• VİLDAN GÖKNUR HALİLOĞLU

Özet henüz yok.

• DİCLEHAN ORHAN

OBJECTIVE: To determine the prevalence of and independent factors associated with joint involvement in a large population of patients with systemic sclerosis (SSc). METHODS: This study was cross-sectional, based on data collected on patients included in the European League Against Rheumatism (EULAR) Scleroderma Trials…

• MEHMET TUNCAY DURUÖZ

OBJECTIVE: Scleroderma (SSc) is an autoimmune disease of unknown etiology. The disease is 3-8 times more frequent in women than in men. The role of X chromosome inactivation (XCI) in the predisposition of women to autoimmunity has been questioned. Until now this has not been illustrated experimentally. This study was…

• CEMALİYE AKYERLİ BOYLU

Sarcopenia refers to a decrease in skeletal muscle mass and function. Because sarcopenia affects mortality, and causes significant disability, the clinical importance of sarcopenia is emerging. At first, sarcopenia was recognized as an age-related disease but, recently, it has been reported to be prevalent also in you…

RATIONALE: Clinical trial design in interstitial lung diseases (ILDs) has been hampered by lack of consensus on appropriate outcome measures for reliably assessing treatment response. In the setting of connective tissue diseases (CTDs), some measures of ILD disease activity and severity may be confounded by non-pulmon…

• NESRİN MOĞULKOÇ BISHOP